• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.

作者信息

Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, Segnan N

出版信息

Eur J Cancer. 1993;29A Suppl 4:S1-38.

PMID:8274301
Abstract
摘要

相似文献

1
European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.《子宫颈癌筛查质量保证欧洲指南》。欧洲抗癌计划。
Eur J Cancer. 1993;29A Suppl 4:S1-38.
2
Quality control in cytopathology applied to screening for cervical carcinoma.应用于宫颈癌筛查的细胞病理学质量控制。
Pol J Pathol. 1995;46(4):245-8.
3
[Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].[法国病理解剖学和细胞学结构中子宫癌筛查涂片内部质量控制评估指南。法国病理解剖学和细胞学质量保证协会（AFAQAP）——宫颈涂片委员会]
Ann Pathol. 1998 Jul;18(3):221-6.
4
Quality assurance in cervical cytopathology.宫颈细胞病理学中的质量保证
Cytopathology. 1997 Aug;8(4):290-2.
5
[Cervical cancer screening. False negative smears].[宫颈癌筛查。涂片检查假阴性]
Rev Med Suisse Romande. 1997 Aug;117(8):597-601.
6
[Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].[关于2008年第28卷第4期的社论。“哥伦比亚的宫颈癌控制：基于细胞学项目的成就与挑战”]
Biomedica. 2009 Mar;29(1):161-2; author reply 162-3.
7
[European guidelines for quality assurance in the screening for cancer of the uterine cervix].[欧洲子宫颈癌筛查质量保证指南]
Ugeskr Laeger. 1994 Mar 14;156(11):1654.
8
ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.细胞技术人员的ASC/SIL比率：筛查敏感性的替代标志物。
Am J Clin Pathol. 2009 Jun;131(6):776-81. doi: 10.1309/AJCPXANG59GPHJNU.
9
European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.欧洲宫颈癌筛查质量保证指南：宫颈细胞学术语推荐
Cytopathology. 2007 Aug;18(4):213-9. doi: 10.1111/j.1365-2303.2007.00469.x.
10
[Personnel training for a population screening program for cervical carcinoma].[子宫颈癌人群筛查项目的人员培训]
Pathologica. 2001 Jun;93(3):233-41.

引用本文的文献

1
Cervical cancer mortality trend in Montenegro-1990-2018.黑山1990 - 2018年宫颈癌死亡率趋势
Eur J Public Health. 2025 Jun 1;35(3):470-476. doi: 10.1093/eurpub/ckaf059.
2
HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review.波斯尼亚和黑塞哥维那的人乳头瘤病毒相关癌症：全面综述
Acta Med Acad. 2024 Dec;53(3):237-273. doi: 10.5644/ama2006-124.458.
3
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
疫苗接种后 HPV 检测准确性的可预测变化：对宫颈筛查中性能监测的影响的综述。
Br J Cancer. 2024 May;130(11):1733-1743. doi: 10.1038/s41416-024-02681-z. Epub 2024 Apr 13.
4
Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review.11个国家的宫颈癌筛查指南与筛查实践：一项系统文献综述
Prev Med Rep. 2022 May 8;28:101813. doi: 10.1016/j.pmedr.2022.101813. eCollection 2022 Aug.
5
Time Trends Analysis of Cervical Cancer Incidence in Cluj County, Romania, Using Data from a Population-Based Cancer Registry.罗马尼亚克卢日县基于人群的癌症登记处的宫颈癌发病率时间趋势分析。
Curr Oncol. 2021 Apr 30;28(3):1706-1717. doi: 10.3390/curroncol28030159.
6
Cervical Cancer Mortality in East-Central European Countries.中东欧国家的宫颈癌死亡率。
Int J Environ Res Public Health. 2020 Jun 28;17(13):4639. doi: 10.3390/ijerph17134639.
7
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).宫颈筛查：欧洲妇科肿瘤学会（ESGO）和欧洲阴道镜学会（EFC）的立场文件
Br J Cancer. 2020 Aug;123(4):510-517. doi: 10.1038/s41416-020-0920-9. Epub 2020 Jun 8.
8
Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients.子宫颈上皮刮片中过表达的TKTL1、CIP-2A和B-MYB蛋白作为HR-HPV感染的低度鳞状上皮内病变/非典型鳞状细胞患者潜在的风险预测生物标志物
Front Oncol. 2019 Apr 3;9:213. doi: 10.3389/fonc.2019.00213. eCollection 2019.
9
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.欧洲的宫颈癌筛查项目：向 HPV 疫苗接种和基于人群的 HPV 检测的转变。
Viruses. 2018 Dec 19;10(12):729. doi: 10.3390/v10120729.
10
Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.机会性筛查诊断的宫颈癌患者是否活得更长？阿尔汉格尔斯克癌症登记研究。
Int J Environ Res Public Health. 2017 Nov 26;14(12):1500. doi: 10.3390/ijerph14121500.